{
    "organizations": [],
    "uuid": "4b0427e6fcb7e8155994e11cc90d43f5ed9dc9e1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ampio-updates-regulatory-and-clini/brief-ampio-updates-regulatory-and-clinical-activities-idUSASC09UPB",
    "ord_in_thread": 0,
    "title": "BRIEF-Ampio Updates Regulatory And Clinical Activities",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 3 (Reuters) - Ampio Pharmaceuticals Inc:\n* AMPIO UPDATES REGULATORY AND CLINICAL ACTIVITIES * ‍RETAINED PAREXEL TO ASSIST IN PREPARING AND PRESENTING BLA FOR AMPION FOR TREATMENT OF OSTEOARTHRITIS-OF—KNEE TO FDA​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-03T20:41:00.000+03:00",
    "crawled": "2018-04-04T12:27:47.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "ampio",
        "pharmaceutical",
        "inc",
        "ampio",
        "update",
        "regulatory",
        "clinical",
        "activity",
        "parexel",
        "assist",
        "preparing",
        "presenting",
        "bla",
        "ampion",
        "treatment",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}